ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending Franklin Resources BEN Q1 2026 Earnings Strong Earnings Beat Overshadows Revenue Uncertainty ADSK Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Despite Strong Quarter BBUC Q1 2026 Earnings Profitability Shines in a Quiet Quarter Biogen Q1 2026 Earnings EPS Surges Past Estimates Stock Rises NFG Q1 2026 Earnings EPS Falls Short of Consensus Stock Dips Slightly